As such, the overall improvement in performance following the application of a higher dose of methylphenidate in the DAT-tg rat may reflect the need for interfering with DAT activity in several implicated brain areas, in order to reverse all aspects of the cognitive deficits seen in the MWM. This evidence concerns the gene SLC6A3 and Cognitive impairment.